Revealing minor spliceosome snrna dysregulation as a diagnostic and therapeutic strategy in prostate cancer
Active Project Grant Awarded Last action
- Award ID
- HT9425261E333
- Recipient
-
Universitat Bern UEI MX7JPQLVM5V5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $2,086,976
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 4% complete
- Place of performance
- Switzerland
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded $2.086 million to Universitat Bern on September 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to support research on minor spliceosome snRNA dysregulation as a diagnostic and therapeutic strategy in prostate cancer. The project runs through August 31, 2030, and is performed in Switzerland. The award funds basic and applied biomedical research aimed at transforming healthcare for Service Members and the American public through innovative research solutions.
Quick answers
Who received award HT9425261E333?
HT9425261E333 was awarded to Universitat Bern by Defense Health Agency (Department of Defense) on September 1, 2026.
How much is award HT9425261E333 worth?
$2,086,976 has been obligated on HT9425261E333.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award